Keynote Lecture 4: The BRAF pathway in CRC?

Keynote Lecture 4: The BRAF pathway in CRC?

What is the optimal therapy for BRAF mutant metastatic colorectal cancer?Подробнее

What is the optimal therapy for BRAF mutant metastatic colorectal cancer?

Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhDПодробнее

Resistance in BRAF and KRAS Mutant Cancers - by Ryan Corcoran, MD, PhD

Triplet Regimens in BRAF-Mutant Metastatic CRCПодробнее

Triplet Regimens in BRAF-Mutant Metastatic CRC

Dr Scott Kopetz Deputy Chair, GI Med Oncology MD Anderson discusses KRAS-directed therapies for CRCПодробнее

Dr Scott Kopetz Deputy Chair, GI Med Oncology MD Anderson discusses KRAS-directed therapies for CRC

BRAF-Mutated mCRC: From Diagnosis to TreatmentПодробнее

BRAF-Mutated mCRC: From Diagnosis to Treatment

Resistance to MAPK pathway inhibition in BRAF mutant colorectal cancersПодробнее

Resistance to MAPK pathway inhibition in BRAF mutant colorectal cancers

Initial Management of Metastatic CRC in 2019Подробнее

Initial Management of Metastatic CRC in 2019

Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodiesПодробнее

Debate: Targeted therapy for RAS/BRAF WT left sided colon cancers - Bevacizumab or EGFR antibodies

Dr. Eng on Ongoing Studies for BRAF-Mutant CRCПодробнее

Dr. Eng on Ongoing Studies for BRAF-Mutant CRC

Dr. Kopetz Discusses Triplet Therapy for BRAF-Mutant CRCПодробнее

Dr. Kopetz Discusses Triplet Therapy for BRAF-Mutant CRC

Mutational Testing and the Treatment of Colorectal CancerПодробнее

Mutational Testing and the Treatment of Colorectal Cancer

Stage IV CRC: The Evolving Role of Molecular SubtypeПодробнее

Stage IV CRC: The Evolving Role of Molecular Subtype

Dr Ryan Corcoran from MGH talks about #BRAF mutated colorectal cancer updates in this #DocTalkПодробнее

Dr Ryan Corcoran from MGH talks about #BRAF mutated colorectal cancer updates in this #DocTalk

Debate: MSI High Colon Cancer - ImmunotherapyПодробнее

Debate: MSI High Colon Cancer - Immunotherapy

Colorectal Cancer Debate: First Line BRAF V600E - Targeted TripletПодробнее

Colorectal Cancer Debate: First Line BRAF V600E - Targeted Triplet

Keynote Lecture 3: Novel clinical applications of cancer genomicsПодробнее

Keynote Lecture 3: Novel clinical applications of cancer genomics

Controversy Debate 4: Treatment algorithms in metastatic CRC - NCCN guidelinesПодробнее

Controversy Debate 4: Treatment algorithms in metastatic CRC - NCCN guidelines

Novel Agents and Targets in Colorectal CancerПодробнее

Novel Agents and Targets in Colorectal Cancer